Loading...
Loading...
India's cyclosporine imports from SOUTH KOREA total $36 across 2 shipments from 2 foreign suppliers. TAEJOON PHARM. CO., LTD. leads with $24 in import value; the top 5 suppliers together control 100.0% of this origin. Leading Indian buyers include DAICEL CHIRAL TECHNOLOGIES (INDIA) PRIVATE LIMITED. This corridor reflects India's pharmaceutical import demand for cyclosporine โ a concentrated sourcing relationship with select suppliers from SOUTH KOREA.

TAEJOON PHARM. CO., LTD. is the leading Cyclosporine supplier from SOUTH KOREA to India, with import value of $24 across 1 shipments. The top 5 suppliers โ TAEJOON PHARM. CO., LTD., TAEJOON PHARM. CO. LIMITED โ collectively account for 100.0% of total import value from this origin.
Ranked by import value (USD) ยท Indian Customs (DGFT) data
| # | Supplier | Value (USD) | Shipments | Share |
|---|---|---|---|---|
| 1 | TAEJOON PHARM. CO., LTD. | $24 | 1 | 66.8% |
| 2 |
| TAEJOON PHARM. CO. LIMITED |
| $12 |
| 1 |
| 33.2% |
Ranked by import value (USD)
| # | Buyer | Value (USD) | Shipments | Share |
|---|---|---|---|---|
| 1 | DAICEL CHIRAL TECHNOLOGIES (INDIA) PRIVATE LIMITED | $36 | 2 | 100.0% |
Answers based on Indian Customs (DGFT) import records compiled by TransData Nexus
The top Cyclosporine suppliers from SOUTH KOREA to India include TAEJOON PHARM. CO., LTD., TAEJOON PHARM. CO. LIMITED. The leading supplier is TAEJOON PHARM. CO., LTD. with import value of $24 USD across 1 shipments. India imported Cyclosporine worth $36 USD from SOUTH KOREA in total across 2 shipments.
India imported Cyclosporine worth $36 USD from SOUTH KOREA across 2 shipments. Data is from Indian Customs (DGFT) records. Values are in USD.
The main Indian buyers of Cyclosporine sourced from SOUTH KOREA include DAICEL CHIRAL TECHNOLOGIES (INDIA) PRIVATE LIMITED. The largest buyer is DAICEL CHIRAL TECHNOLOGIES (INDIA) PRIVATE LIMITED with $36 in imports across 2 shipments.
The total value of Cyclosporine imports from SOUTH KOREA to India is $36 USD, across 2 shipments and 2 foreign suppliers. Data source: Indian Customs (DGFT).
Pharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormareAll trade data is sourced from Indian Customs (DGFT) official shipping bill records โ the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
2 Verified Shipments
2 suppliers, 1 buyers tracked
Expert-Reviewed
By pharmaceutical trade specialists